NEWS
Institutional Subscription: Comprehensive Analyses to Enhance Your Global and Local Impact
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Daniel G Anderson
Massachusetts Institute of Technology - Cambridge / United States
Engineering & Technology / Bioengineering
AD Scientific Index ID: 1411966
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Daniel G Anderson's MOST POPULAR ARTICLES
1-)
Knocking down barriers: advances in siRNA deliveryKA Whitehead, R Langer, DG AndersonNature reviews Drug discovery 8 (2), 129-138, 200932902009
2-)
Non-viral vectors for gene-based therapyH Yin, RL Kanasty, AA Eltoukhy, AJ Vegas, JR Dorkin, DG AndersonNature Reviews Genetics 15 (8), 541-555, 201427162014
3-)
Physical and mechanical properties of PLA, and their functions in widespread applications—A comprehensive reviewS Farah, DG Anderson, R LangerAdvanced drug delivery reviews 107, 367-392, 201619462016
4-)
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised …B Burtness, KJ Harrington, R Greil, D Soulières, M Tahara, G de Castro, ...The Lancet 394 (10212), 1915-1928, 201927232019
5-)
CRISPR-Cas9 knockin mice for genome editing and cancer modelingRJ Platt, S Chen, Y Zhou, MJ Yim, L Swiech, HR Kempton, JE Dahlman, ...Cell 159 (2), 440-455, 201421382014
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept